南京澳林生物科技有限公司
Introduction of Nanjing Aubrime Biotechnology Co., LTD.
南京澳林生物科技有限公司是具有全球經營戰略和先進技術的生物醫藥研發、制造、銷售一體化企業，公司成立于2007年，占地26. 6畝,注冊資金2210萬元，以建設“讓全人類共享科學早診高速公路”為己任，以“專注生命、精工精品”為宗旨，目前主要致力于臨床化學及分子生物學診斷試劑產品，檢驗儀器的研究、開發、生產和銷售，以及第三方獨立醫學檢驗平臺的建設。
Nanjing Aubrime Biotechnology Co., Ltd. is a comprehensive company of R&D, manufacturing and marketing of biomedical products, with corporate global strategy and advanced technology. Nanjing Aubrime was founded in 2007, covering an area of 26.6 Chinese Mu, with a registered capital of 22.1 million RMB. With “building early diagnostic expressway” as its duty and “focusing on life, manufacturing product of exquisite quality” as its tenet, Aubrime has been committing itself to the research, development, manufacturing and marketing of laboratory instruments and clinical diagnostic reagents and the construction of independent clinical laboratory platform.
現有上市產品110余項，產品覆蓋有腦卒中早篩、胃癌早篩、心梗早篩、糖尿病漏診控制和抗生素濫用檢測控制五大臨床診斷系列產品，產品技術覆蓋生物化學、免疫學、分子生物學和臨床診斷醫學等領域，能夠持續滿足臨床診斷檢測需求。質量管理體系已通過了IS09001:2015和IS013485:2016雙標準認證，15個產品被評為南京市生物醫藥新產品，是一家致力于以臨床疾病為導向的全自動生化系統產品的研發制造商，也是腦卒中早篩分級與預警系統診斷領域技術創新的推動者。
Currently, there are over 110 products available on the market from Aubrime, which covering a series products of early screening products of stroke, gastric cancer and cardiac infarction, control of missed diagnosis of diabetes and abuse control of antibiotics. product technology covers biochemistry, immunology, molecular biology and clinical diagnostic medicine and other fields, can continuously meet the needs of clinical diagnosis and detection. Aubrime’s quality management system has passed the certification of ISO9001:2015 and ISO13485:2016, 15 of Aubrime’s products were selected as the“Novel Biomedical Products in Nanjing”. Aubrime is a R&D manufacturer of devoting to fully automatic biochemical system products oriented clinical disease, and also the pioneer of improving technical innovation in the field of Early Screening&Classifying and Alarm & Diagnostic System of Stroke.
目前是南京大學生命科學產學研基地，南京市醫藥生物工程技術研究中心，南京市慢病診斷工程研究中心，國家高新技術企業，江蘇省“專精特新”企業，科技型中小企業，江蘇省知識產權貫標優秀企業，連續多年被評為行業內誠信企業，2017年度AAA級資信企業，2019年6月入選南京市瞪羚企業榜單。
Currently, Aubrime is the research, study and manufacturing base of the Life Science Institute of Nanjing University and the R&D center of Nanjing Medical Bioengineering Technology, Nanjing Chronic Disease Diagnostic Engineering Research Center, National High-tech Enterprise, Jiangsu "Specialized Special New" enterprise, Small and Medium-sized Sci-tech Enterprises, and excellent enterprise of intellectual property standard implementation in Jiangsu Province. Aubrime was awarded as the Credit Enterprise for many consecutive years,and AAA level Credit Enterprise in 2017. Aubrime won the title of ''Nanjing Gazelle Enterprise'' in June 2019.
質量為先，服務至上，以優質的產品和服務樹百年品牌；目前一百余種的液體及干粉診斷試劑主要與醫院渠道服務商、生物技術企業以及多個著名科研院校進行業務合作。
Quality First, Service Uppermost. Aubrime has been committing to building a brand, famous for supreme quality and service.Currently, Aubrime has been cooperating with hospital channel suppliers, biotech companies and many famous institutes or universities on over 100 liquid or freeze-dried diagnostic reagents.
2018年5月組建成立第三方獨立醫學檢驗平臺，以先進的技術，專業的服務，打造規范的第三方醫學檢驗實驗室，實驗室使用面積2000平方米，人員結構合理，各種專業設備齊全，主要開展臨床血液、體液檢驗,臨床化學、臨床微生物學、臨床免疫學和分子生物學檢驗，主要致力于為客戶提供“醫學診斷服務整體化解決方案”。
In May 2018, the independent clinical laboratory platform was established to build a standardized independent clinical laboratory with advanced technology and professional services. The laboratory covers an area of 2000 square meters, has a reasonable staff structure and a variety of professional equipment. It mainly conducts clinical blood and body fluid tests, clinical chemistry, clinical microbiology, clinical immunology and molecular biology tests. The company is committed to providing customers with "Integrated Solutions Of Medical Diagnostic Services ".
以技術為保證，用創新求發展，澳林生物將積極推動國際臨床檢驗事業和中國臨床檢驗行業的發展，為全人類的健康不懈努力和做出更多的貢獻。
Taking technology as quarantee, developing with innovation, Aubrime will continue to make greater efforts and contribute more to the testing cause of national and international clinical testing industry.
澳林期待你的支持與參與！
Aubrime is looking forward to your support and participation!
